With an eye toward pandemic preparedness, a U.N.-backed agency has signed sub-licensing deals related to generic versions of ...

The Justice Department said in June that it would no longer enforce laws that prioritized people with disabilities living and ...

With this latest appointment, mifepristone has a new boss but an old problem,” writes Julie F. Kay, founder and CEO of ...

Kyverna Therapeutics is one step closer to launching the first cell therapy for an autoimmune disease, with new data in hand ...

The FDA approved Eli Lilly’s Onswik, a once-weekly basal insulin for adults with type 2 diabetes, offering patients an ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. The World Health Organization late ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

Klomp is currently senior adviser to health secretary Robert F. Kennedy Jr. He was advanced by the Senate Committee on ...

Gilead Sciences’ top executives have been emphatically bullish about the biotech’s years-long push to develop drugs for ...

Heidi Overton, President Trump’s nominee to lead the Food and Drug Administration, was grilled by senators on hot-button ...

Exclusive: Heidi Overton plans to tell senators she will speed up biomedical research, working with FDA staff.